BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services
August 15, 2018 09:00 ET
|
BioStem Technologies, Inc.
Fort Lauderdale, FL, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), (the “Company” or “BioStem Technologies”) a global life sciences corporation, providing innovative...
BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products
August 09, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), BioStem Technologies, Inc. is a global life sciences corporation,...
BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative
August 08, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 08, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies (BSEM) Subsidiary Nesvik Pharmaceuticals Announces the Completion of An Asset Purchase of Multiple New Drug Compounds and Launches Joint Development Venture with CCM Pharma Solutions
July 19, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 19, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals (f/k/a BioStem Pharmaceuticals), a subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”),...
BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients
June 18, 2018 17:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Enters Into Consulting and Advisory Agreement with Dr. Irmgard Huber
April 04, 2018 10:28 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, April 04, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies, Inc. Announces Letter of Intent with CCM Pharma Solutions to Co-Develop Multiple Solid to Liquid Dose Drugs Through 505(b)(2) Accelerated FDA Approval Process
March 26, 2018 19:22 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a...
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
March 13, 2018 18:16 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific Affairs
March 09, 2018 17:09 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...
BioStem Technologies Inc. Announces Intent to Acquire GIINT
February 26, 2018 20:27 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...